Pharmacogenomic biomarkers: Validation needed for both the molecular genetic mechanism and clinical effect

Pharmacogenomics

Volumn 12, Issue 5, 2011, Pages 675-680

  Sadee, Wolfgang ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

biomarkers; gene expression; pharmacogenomics; serotonin transporter; structural RNA polymorphisms

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; SEROTONIN TRANSPORTER;

ADVERSE DRUG REACTION; CLINICAL PRACTICE; DEPRESSION; DNA POLYMORPHISM; GENE INTERACTION; GENETIC MARKER; GENETIC VARIABILITY; HUMAN; MOLECULAR GENETICS; PERSONALIZED MEDICINE; PHARMACOGENOMICS; REGULATORY SEQUENCE; REVIEW; RNA STRUCTURE; SINGLE NUCLEOTIDE POLYMORPHISM; STANDARDIZATION; TREATMENT RESPONSE; VALIDATION STUDY;

ANIMALS; BIOLOGICAL MARKERS; GENETIC MARKERS; GENETIC VARIATION; HUMANS; INDIVIDUALIZED MEDICINE; PHARMACOGENETICS; POLYMORPHISM, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 79957630478     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.11.23     Document Type: Review

References (21)

1. Johnson AD, Wang D, Sadee W: Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics. Pharmacol. Ther. 106, 19-38 (2005). (Pubitemid 40392460)
2. Sadee W: Measuring ra-acting regulatory variants genome-wide: new insight into expression genetics and disease susceptibility Genome Med. 1, 116 (2009).
3. Sadee W, Wang D, Papp AC et al\ Pharmacogenomics of the RNA world: structural RNA polymorphisms in drug therapy. Clin. Pharmacol. Ther. 89(3), 355-365 (2011).
4. Hindorff LA, Sethupathy P, Junkins HAet al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl Acad. Sa. USA 106, 9362-9367 (2009).
5. Heap GA, Yang JH, Downes Ket al. Genome-wide analysis of allelic expression imbalance in human primary cells by high throughput transcriptome resequencing. Hum. Mol. Genet. 19, 122-134 (2010).
6. Zhang Y, Wang DX, Johnson AD, Papp AC, Sadee W: Allelic expression imbalance of human u opioid receptor (OPRMl) caused by variant A118G. J. Biol. Chem. 280, 32618-3224 (2005).
7. Smith RM, Alachkar H, Papp ACet al. Nicotinic a5 receptor subunk mRNA expression is associated with distant 5' upstream polymorphisms. Eur. J. Hum. Gen. 19(1), 76-83 (2011).
8. Wang D, Chen H, Momary KM, Cavallari LH, Johnson JA, Sadee W: Regulatory polymorphism in vitamin K epoxide reductase complex subunk 1 {VKORCl) affects gene expression and warfarin dose requirement. Blood 112, 1013-1021 (2008).
9. Johnson AD, Zhang Y, Papp ACet al. Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues. Pharmacogenet. Genomics 18,781-791 (2008).
10. Ge B, Pokholok DK, Kwan T et ah. Global patterns of cis variation in human cells revealed by high-density allelic expression analysis. Nat. Genet. 41, 1216-1222 (2009).
11. Cooper TA, Wan L, Dreyfuss G: RNA and disease. Cell 136, 777-793 (2009).
12. Wang GS, Cooper TA: Splicing in disease: disruption of the splicing code and the decoding machinery. Nat. Rev. Genet. 8, 749-761 (2007). (Pubitemid 47429207)
13. Wang D, Papp AC, Binkley PF, Johnson JA, Sadee W: Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel a subunk 1C (CACNAlC) in human heart tissues. Pharmacogent. Genomics 16,735-745 (2006). (Pubitemid 44454868)
14. Zhang Y, Bertolino A, Fazio Let al. Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc. Natl Acad. Sci. USA 104, 20552-20557 (2007).
15. Moyer RA, Wang D, Papp ACet al. Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse. Neuropsychopharmacology 36(4), 753-762 (2011).
16. Johnson AD, Gong Y, Wang Det al. Promoter polymorphisms in ACE (angiotensin-I converting enzyme) associated wkh clinical outcomes in hypertension. Clin. Pharmacol. Ther. 85, 36-44 (2009).
17. Manolio TA, Collins FS, Cox NJet al. Finding the missing herkabilky of complex diseases. Nature461, 747-753 (2009).
18. Caspi A, Sugden K, Moffitt TEet al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386-389 (2003). (Pubitemid 36877077)
19. LeschKP, Bengel D, W&Ws Aet al. Association of anxiety-related traits wkh a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527-1531 (1996).
20. Risch N, Herrell R, Lehner Tet al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 301,2462-2471 (2009).
21. Lim JE, Papp A, Pinsonneault J, Sadee W, Saffen D: Allelic expression of serotonin transporter (SERT) mRNA in human pons: lack of correlation wkh the polymorphism SERTLPR. Mol. Psychiatry 11, 649-662 (2006). (Pubitemid 43989812)